Martinot M, et al. Analysis of delays in the prescription of oseltamivir in hospitals and potential for improvement. Med Mal Infect. 2018 Nov 13
Patients hospitalized for influenza should receive early treatment with a neuraminidase inhibitor.
PATIENTS AND METHODS:
We conducted a retrospective study of the prescription of oseltamivir during the 2016-2017 influenza epidemic among patients hospitalized for influenza confirmed by RT-PCR in the infectious disease department.
Treatment with oseltamivir was initiated as recommended in 96% of hospitalized patients presenting with influenza. However, a delay in prescription was observed with only 18% of prescriptions made on the first day. The prescriptions were exclusively initiated in the infectious disease department.
To improve the early prescription of oseltamivir during the influenza season, two recommendations are essential: oseltamivir availability in the emergency department pharmacy, awareness of physicians of the need to prescribe to any patient hospitalized for a lower respiratory tract infection treatment with a neuraminidase inhibitor upon admission to the emergency department.
- Linear ubiquitin assembly complex regulates lung epithelial driven responses during influenza infection 2 days ago
- Reverse transcription recombinase-aided amplification assay for H7 subtype avian influenza virus 2 days ago
- Highly Pathogenic and Low Pathogenic Avian Influenza H5 Subtype Viruses in Wild Birds in Ukraine 2 days ago
- Efficacy of Clade 2.3.2 H5-Recombinant Baculovirus Vaccine in Protecting Muscovy and Pekin Ducks from Clade 126.96.36.199 H5N8 Highly Pathogenic Avian Influenza Infection 2 days ago
- Type I interferon antagonistic properties of Influenza B virus polymerase proteins 2 days ago